Workflow
可换股债券转换
icon
Search documents
大成生化科技完成根据特别授权发行代价股份及转换可换股债券
Zhi Tong Cai Jing· 2025-10-02 11:29
公司接获债券持有人发出的转换通知,内容有关悉数行使其于可换股债项下的转换权,并以每股转换股 份0.21港元的转换价将本金金额为10.86亿港元的可换股债券转换为51.73亿股转换股份。因此,于完成 配发转换股份所需的必要行政程序后,公司已于2025年10月2日向债券持有人配发及发行51.73亿股转换 股份,该等股份在所有方面与彼此之间及所有其他已发行现有股份享有同等地位(转换)。 大成生化科技(00809)发布公告,董事会欣然宣布,股份购买协议I及股份购买协议II各自项下的所有先 决条件均已获达成,且根据各股份购买协议的条款及条件,股份购买协议已于2025年10月2日完成。合 共27.53亿股代价股份已发行。 ...
百仕达控股(01168.HK)预期中期拥有人应占亏损不超过5.35亿港元
Ge Long Hui· 2025-08-08 12:35
Core Viewpoint - The company, Bestar Holdings (01168.HK), anticipates a significant increase in losses for the six months ending June 30, 2025, projecting a loss of no more than HKD 535 million compared to a loss of approximately HKD 150.5 million in the same period last year, primarily due to fair value losses on convertible bonds [1] Financial Performance - The projected loss for the upcoming reporting period is attributed mainly to a fair value loss of approximately HKD 497.9 million related to convertible bonds [1] - The company will recognize an additional non-cash accounting adjustment loss of about HKD 476.5 million in its annual results for the year ending December 31, 2025, due to the conversion of convertible bonds [1] Corporate Actions - On July 24, 2025, all holders of the convertible bonds exercised their conversion rights, resulting in the issuance of 117,647,058 shares on July 25, 2025 [1]